Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy. IJRDT [Internet]. 2026 Mar. 18 [cited 2026 Sep. 10];4(1):85-109. Available from: https://ijrdt.com/index.php/files/article/view/170